Clinical Reference Laboratory Testing Services

SOL #: HT001526RE001AMD0001Solicitation

Overview

Buyer

DEPT OF DEFENSE
Defense Health Agency (Dha)
DHA ENTERPRISE MED SUPPORT EMS-CD
FORT SAM HOUSTON, TX, 78234, United States

Place of Performance

Place of performance not available

NAICS

Medical Laboratories (621511)

PSC

Reference Laboratory Testing (Q301)

Set Aside

No set aside specified

Timeline

1
Posted
May 21, 2026
2
Submission Deadline
Jun 1, 2026, 5:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

Amendment 0001 to RFP HT001526RE001 for Clinical Reference Laboratory Testing Services (CRLTS) has been released by the Defense Health Agency (DHA). This amendment provides Government responses to industry questions and updates key solicitation documents, including Addendums to FAR 52.212-1 and FAR 52.212-2. All other terms and conditions of the original solicitation remain unchanged. Proposals are due by June 1, 2026, at 5:00 PM UTC.

Scope of Change

This amendment incorporates:

  • Revised Addendums to FAR 52.212-1 (Instructions to Offerors) and FAR 52.212-2 (Evaluation Criteria).
  • Exhibit B - Q&A Matrix containing Government responses to submitted questions.

Key Clarifications & Instructions

  • Proposal Submission: Proposals must be submitted via email, consisting of five separate volumes: Business, Technical, Performance Risk, Small Business Subcontracting, and Price. Strict formatting (11-point font, 1-inch margins) and page limitations (e.g., 45 pages for Technical) apply. Only the last complete proposal submitted by the deadline will be evaluated.
  • Evaluation Factors: Award will be based on a best-value tradeoff process. Evaluation factors, in descending order of importance, are: Technical, Performance Risk, Small Business Subcontracting Participation, and Price. Non-price factors combined are significantly more important than Price.
  • Technical Requirements: Proposals must demonstrate capability to meet PWS requirements, including Cybersecurity (mandatory CMMC Final Level 2 Self-Assessment in SPRS for award), Transition and LIS Deployment, Technical Requirements, Quality Control/Assurance, and Supply Chain Management.
  • Small Business Participation: The Small Business Subcontracting Participation factor remains. Offerors must demonstrate a 'Good Faith Effort' if quantitative goals cannot be met, supported by verifiable documentation. Relying solely on a Commercial Subcontracting Plan with lower goals will result in an 'Unacceptable' rating for this factor.
  • Performance Risk: Requires a minimum of three and a maximum of five contract references, including Past Performance Summary Sheets and Questionnaires (PPQs).
  • Pricing: Firm-fixed prices are required for all CLINs for the entire ten-year period. A combined 5% ceiling for Technology and Pricing Refresh (TPR) and Economic Price Adjustment (EPA) applies cumulatively over the contract term. The EPA is tied to the Producer Price Index (PPI) for NAICS 621511.
  • Turnaround Time (TAT): TAT is an all-inclusive, end-to-end metric from specimen pickup to result availability in MHS GENESIS. Offerors must define their TAT metrics to establish a contract baseline.
  • Onsite Personnel: The requirement for onsite personnel is triggered only if both 2,000 specimens per month AND $30,000 in monthly expenditure thresholds are met simultaneously, based on a rolling quarterly average.

Contract & Timeline

  • Contract Opportunity Type: Solicitation (Amendment)
  • Product/Service Code: Q301 (Reference Laboratory Testing)
  • Response Due: June 1, 2026, 5:00 PM UTC
  • Published Date: May 21, 2026
  • Set-Aside: None specified (Small Business Subcontracting is an evaluation factor).

Submission Impact

Offerors must carefully review the updated FAR addendums and the Q&A matrix to ensure full compliance with detailed proposal preparation, submission, and evaluation criteria. Failure to adhere to these instructions may result in an unacceptable proposal.

People

Points of Contact

Tamara FenwickPRIMARY
Michael T. BilickiSECONDARY

Files

Files

Download
Download
Download
Download

Versions

Version 1Viewing
Solicitation
Posted: May 21, 2026
Clinical Reference Laboratory Testing Services | GovScope